Literature DB >> 16574996

Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?

Willem J van Heeckeren, Shyam Bhakta, Jose Ortiz, Jeff Duerk, Matthew M Cooney, Afshin Dowlati, Keith McCrae, Scot C Remick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16574996     DOI： 10.1200/JCO.2005.04.8801

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

1.  A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival.

Authors:  Suchismita Mohanty; Zixin Chen; Kai Li; Goreti Ribeiro Morais; Jessica Klockow; Ketan Yerneni; Laura Pisani; Frederick T Chin; Siddharta Mitra; Samuel Cheshier; Edwin Chang; Sanjiv Sam Gambhir; Jianghong Rao; Paul M Loadman; Robert A Falconer; Heike E Daldrup-Link
Journal:  Mol Cancer Ther       Date:  2017-06-28       Impact factor: 6.261

2.  Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.

Authors:  Michael L Maitland; Kristen E Kasza; Theodore Karrison; Kristin Moshier; Laura Sit; Henry R Black; Samir D Undevia; Walter M Stadler; William J Elliott; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

3.  A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

Authors:  Marc C Chamberlain; Sean Grimm; Surasak Phuphanich; Larry Recht; Jay Z Zhu; Lyndon Kim; Steve Rosenfeld; Camilo E Fadul
Journal:  J Neurooncol       Date:  2014-04-17       Impact factor: 4.130

4.  A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.

Authors:  Colin J Mooney; Govardhanan Nagaiah; Pingfu Fu; Jay K Wasman; Matthew M Cooney; Panos S Savvides; Joseph A Bokar; Afshin Dowlati; Ding Wang; Sanjiv S Agarwala; Susan M Flick; Paul H Hartman; Jose D Ortiz; Pierre N Lavertu; Scot C Remick
Journal:  Thyroid       Date:  2009-03       Impact factor: 6.568

Review 5.  Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.

Authors:  Kelly L Snider; Michael L Maitland
Journal:  Target Oncol       Date:  2009-04-17       Impact factor: 4.493

6.  Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.

Authors:  Parmeswaran Diagaradjane; Anil Shetty; James C Wang; Andrew M Elliott; Jon Schwartz; Shujun Shentu; Hee C Park; Amit Deorukhkar; R Jason Stafford; Sang H Cho; James W Tunnell; John D Hazle; Sunil Krishnan
Journal:  Nano Lett       Date:  2008-04-16       Impact factor: 11.189

Review 7.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

8.  A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.

Authors:  Anne M Traynor; Michael S Gordon; Dona Alberti; David S Mendelson; Mark S Munsey; George Wilding; Richard E Gammans; William L Read
Journal:  Invest New Drugs       Date:  2009-05-13       Impact factor: 3.850

9.  Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.

Authors:  Celina Ansari; Grigory A Tikhomirov; Su Hyun Hong; Robert A Falconer; Paul M Loadman; Jason H Gill; Rosalinda Castaneda; Florette K Hazard; Ling Tong; Olga D Lenkov; Dean W Felsher; Jianghong Rao; Heike E Daldrup-Link
Journal:  Small       Date:  2013-08-27       Impact factor: 13.281

Review 10.  Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Authors:  Adriana Albini; Giuseppina Pennesi; Francesco Donatelli; Rosaria Cammarota; Silvio De Flora; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2009-12-10       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.